Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function

BACKGROUND: There is an urgent need to identify differentiating and disease-monitoring biomarkers of schizophrenia, bipolar disorders (BD), and major depressive disorders (MDD) to improve treatment and management. METHODS: We recruited 54 first-episode schizophrenia (FES) patients, 52 BD patients, 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hua, Ni, Peiyan, Zhao, Liansheng, Tian, Yang, Li, Mingli, Li, Xiaojing, Wei, Wei, Wei, Jinxue, Deng, Wei, Du, Xiangdong, Wang, Qiang, Guo, Wanjun, Ma, Xiaohong, Coid, Jeremy, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235770/
https://www.ncbi.nlm.nih.gov/pubmed/37275985
http://dx.doi.org/10.3389/fpsyt.2023.1180720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235770/
https://www.ncbi.nlm.nih.gov/pubmed/37275985
http://dx.doi.org/10.3389/fpsyt.2023.1180720

Ejemplares similares